Feed

Mostra solo
02/04/2020
Emer­gen­za epi­de­mio­lo­gi­ca da CO­VID-19
Mi­su­re a fa­vo­re de­gli ope­ra­to­ri del mer­ca­to as­si­cu­ra­ti­vo
30 mar 20
ESMA and FCA cla­ri­fy su­per­vi­so­ry ap­proach on SF­TR bac­kloa­ding re­qui­re­men­ts...
This in­for­ma­tion is cor­rect as of 11.30am on 30 March 2020 and will not be main­tai­ned. The Eu­ro­pean Se­cu­ri­ties Mar­ke­ts Au­tho­ri­ty (“ESMA”) has cla­ri­fied its po­si­tion on the re­qui­re­men­ts for ‘bac­kloa­ding’...
01/04/2020
Eti­chet­ta­tu­ra d'o­ri­gi­ne dei pro­dot­ti ali­men­ta­ri: in...
30 mar 20
EU Com­mis­sion calls for clo­ser scru­ti­ny of fo­rei­gn di­rect in­vest­ment
Non-EU in­ve­stors may be con­fron­ted with mo­re ri­gid clea­ran­ce pro­ces­ses when at­temp­ting to ac­qui­re EU com­pa­nies as a re­sult of an un­pre­ce­den­ted call for ac­tion by the Eu­ro­pean Com­mis­sion. In a po­li­cy pa­per...
31 mar 20
CO­VID-19's im­pact on dead­li­nes and pro­ce­du­ral ti­me­ta­bles
Be­fo­re courts, na­tio­nal in­tel­lec­tual pro­per­ty of­fi­ces...
27 mar 20
Ma­na­ging cli­ni­cal trials un­der CO­VID-19: New EU gui­dan­ce is­sued for...
The CO­VID-19 pan­de­mic has had a dra­ma­tic im­pact on Eu­ro­pean health sy­stems, who­se prio­ri­ty fir­st and fo­re­mo­st is the treat­ment of pa­tien­ts suf­fe­ring from this di­sea­se both in the in-pa­tient and out-pa­tient...
CMS Ex­pert Gui­de to CO­VID-19 Im­pact on Lea­se Agree­men­ts
26 mar 20
Doing ar­bi­tra­tion dif­fe­ren­tly: do­cu­men­ts-on­ly ar­bi­tra­tion du­ring the...
The di­srup­tion cau­sed by the CO­VID-19 pan­de­mic has left com­pa­nies across the world scram­bling to main­tain a sen­se of con­ti­nui­ty, as their exe­cu­ti­ves, em­ployees and ad­vi­sers ad­ju­st to li­fe un­der go­vern­ment-im­po­sed...
30/03/2020
At­te­sta­zio­ni ca­me­ra­li su di­chia­ra­zio­ni di sus­si­sten­za...
26 mar 20
Eu­ro­pean Com­mis­sion pro­po­ses de­lay­ing the May 2020 ap­pli­ca­tion of...
The Eu­ro­pean Com­mis­sion has con­fir­med it is wor­king on a pro­po­sal to de­lay for one year the da­te of ap­pli­ca­tion of the new EU Me­di­cal De­vi­ces Re­gu­la­tion 2017/745/EU (the “MDR”) in light of the Co­vid-19...
CMS Ex­pert Gui­de to Com­pe­ti­tion Law Du­ring Co­ro­na­vi­rus...
26 mar 20
ESMA and FCA is­sue sta­te­men­ts con­cer­ning re­gu­la­to­ry for­bea­ran­ce for...
Cor­rect as of 12pm on 23 March. This ar­ti­cle is not being main­tai­ned. On 18 March 2020, the Eu­ro­pean Se­cu­ri­ties and Mar­ke­ts Au­tho­ri­ty (“ESMA”) pu­bli­shed a sta­te­ment about  re­gu­la­to­ry for­bea­ran­ce...